Study of an antibiotic for children with urinary tract infections
This study tests a new antibiotic for children with difficult-to-treat urinary tract infections (UTIs). The medicine is given through an IV and may help when other antibiotics haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged from birth to under 18 years
- Diagnosed with a complicated urinary tract infection (UTI) or kidney infection requiring IV treatment in the hospital
- Have at least two signs of a UTI, such as fever, pain, or nausea
- Had an evaluation to confirm the bacteria causing the infection is likely to respond to the study drug
- test
- test2
- test3
- test4
- test5
- test6
- test7
- test8
- test9
- test10
- test11
- test12
- test13
- test14
- test15
- test16
- test17
- test18
- test19
- test20
- test21
- test22
- test23
- test24
- test25
- test26
- test27
- test28
- test29
- test30
- test31
- test32
- test33
- test34
- test35
- test36
- test37
- test38
- test39
- test40
- test41
- test42
- test43
- test44
- test45
- test46
- test47
- test48
- test49
- test50
- test51
- test52
- test53
- test54
- test55
- test56
- test57
- test58
- test59
- test60
- test61
- test62
- test63
- test64
- test65
- test66
- test67
- test68
- test69
- test70
- test71
- test72
- test73
- test74
- test75
- test76
- test77
- test78
- test79
- test80
- test81
- test82
- test83
- test84
- test85
- test86
- test87
- test88
- test89
- test90
- test91
- test92
- test93
- test94
- test95
- test96
- test97
- test98
- test99
- test100
- test101
- test102
- test103
- test104
- test105
- test106
- test107
- test108
- test109
- test110
- test111
- test112
- test113
- test114
- test115
- test116
- test117
- test118
- test119
- test120
- test121
- test122
- test123
- test124
- test125
- test126
- test127
- test128
- test129
- test130
- test131
- test132
- test133
- test134
- test135
- test136
- test137
- test138
- test139
- test140
- test141
- test142
- test143
- test144
- test145
- test146
- test147
- test148
- test149
- test150
- test151
- test152
- test153
- test154
- test155
- test156
- test157
- test158
- test159
- test160
- test161
- test162
- test163
- test164
- test165
- test166
- test167
- test168
- test169
- test170
- test171
- test172
- test173
- test174
- test175
- test176
- test177
- test178
- test179
- test180
- test181
- test182
- test183
- test184
- test185
- test186
- test187
- test188
- test189
- test190
- test191
- test192
- test193
- test194
- test195
- test196
- test197
- test198
- test199
- test200
- test201
- test202
- test203
- test204
- test205
- test206
- test207
- test208
- test209
- test210
- test211
- test212
- test213
- test214
- test215
- test216
- test217
- test218
- test219
- test220
- test221
- test222
- test223
- test224
- test225
- test226
- test227
- test228
- test229
- test230
- test231
- test232
- test233
- test234
- test235
- test236
- test237
- test238
- test239
- test240
- test241
- test242
- test243
- test244
- test245
- test246
- test247
- test248
- test249
- test250
- test251
- test252
- test253
- test254
- test255
- test256
- test257
- test258
- test259
- test260
- test261
- test262
- test263
- test264
- test265
- test266
- test267
- test268
- test269
- test270
- test271
- test272
- test273
- test274
- test275
- test276
- test277
- test278
- test279
- test280
- test281
- test282
- test283
- test284
- test285
- test286
- test287
- test288
- test289
- test290
- test291
- test292
- test293
- test294
- test295
- test296
- test297
- test298
- test299
- test300
- test301
- test302
- test303
- test304
- test305
- test306
- test307
- test308
- test309
- test310
- test311
- test312
- test313
- test314
- test315
- test316
- test317
- test318
- test319
- test320
- test321
- test322
- test323
- test324
- test325
- test326
- test327
- test328
- test329
- test330
- test331
- test332
- test333
- test334
- test335
- test336
- test337
- test338
- test339
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether giving just one dose of an intravenous (IV) antibiotic can safely treat complicated urinary tract infections (UTIs) in children. It aims to see if this shorter approach works as well as standard treatment while still preventing complications.
This trial tests a new antibiotic combination, cefepime/enmetazobactam, against standard therapy for people with complicated urinary tract infections that have spread to the bloodstream. It aims to see if the new drug works better and is safe.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This study tests a new combination of two antibiotics (meropenem and pralurbactam) given through an IV to treat serious abdominal infections. It is for adults who need hospital care and might be helped by a stronger infection-fighting drug.
This study is looking at how well two strong antibiotics (ceftazidime/avibactam and cefiderocol) work, with or without another drug called fosfomycin, for treating tough Gram-negative infections. It aims to help doctors understand the best way to use these medicines.
Hear when a new Complicated Urinary Tract Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.